Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Integrated sphingosine-1 phosphate signaling in the central nervous system: From physiological equilibrium to pathological damage.
The Neurocognitive Profile of the Cerebellum in Multiple Sclerosis.
Patterns in workplace accommodations for people with multiple sclerosis to overcome cognitive and other disease-related limitations.
Glial metabotropic glutamate receptor-4 increases maturation and survival of oligodendrocytes.
Changes in different parameters, lymphocyte proliferation and hematopoietic progenitor colony formation in EAE mice treated with myelin oligodendrocyte glycoprotein.
Influenza-associated MOG antibody-positive longitudinally extensive transverse myelitis: a case report.
miR-155-3p Drives the Development of Autoimmune Demyelination by Regulation of Heat Shock Protein 40.
[Current concepts on intrathecal humoral immune response and diagnostic importance of oligoclonal immunoglobulins in multiple sclerosis].
[TERIFLUNOMIDE: NEW ORAL IMMUNMODULANT DRUG IN THERAPY OF MULTIPLE SCLEROSIS].
Antibody biomarkers in CNS demyelinating diseases - a long and winding road.
No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.
Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.
Neuromyelitis optica spectrum disorders without and with autoimmune diseases.
A logically derived diet to stop MS relapses.
Charcot-Marie-Tooth type 1C disease coexisting with progressive multiple sclerosis: a study of an overlapping syndrome.
Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
Vitamin D: A Narrative Review Examining the Evidence for Ten Beliefs.
Post-operative quadriplegia as the initial manifestation of tumefactive multiple sclerosis.
Optimization of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Evaluated by Grip Strength Measurement.
Novel characterization of gait impairments in people with multiple sclerosis by means of the gait profile score.
Association of TIM-1 5383-5397ins/del and TIM-3 -1541C>T polymorphisms with multiple sclerosis in Isfahan population.
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes.
Involvement of CD8(+) T Cells in Multiple Sclerosis.
Hyaluronan synthesis is necessary for autoreactive T-cell trafficking, activation, and Th1 polarization.
Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders.
Pages
« first
‹ previous
…
584
585
586
587
588
589
590
591
592
…
next ›
last »